PI Industries DuPont analysis

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.77×0.78×0.78×0.89×0.86×
1.33×1.31×1.17×1.10×1.09×
17.4%19.3%22.9%22.3%20.3%
0.52×0.52×0.69×0.80×0.80×
1.20×1.20×1.21×1.23×1.18×
11.1%12.2%17.4%21.6%17.8%
12.2%12.2%17.5%21.1%18.5%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

PIIND₹2,110.00

PI Industries Ltd.

· Chemicals
₹ CrorePeersUPLRALLISSUMICHEMCOROMANDELSRFSOLARINDSPIDILITINDBASFMcap ₹32,072 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.860.890.780.780.77
Interest Burden (Pretax/EBIT) ×1.091.101.171.311.33
EBIT Margin %20.2622.2622.8919.2617.41
Asset Turnover ×0.800.800.690.520.52
Financial Leverage (Assets/Equity) ×1.181.231.211.201.20
ROE (5-step product, year-end total equity) %17.8521.6317.3612.2511.13
ROE (owners' profit / average owners' equity) %18.4621.1117.4712.1612.16
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.